Science No Salve For J&J In Talc Cases, $417M Verdict Shows

Law360, Los Angeles (August 22, 2017, 11:45 PM EDT) -- Johnson & Johnson's $417 million loss in the first California jury trial over the alleged link between its talcum products and ovarian cancer, following a string of defeats in Missouri, highlights the drugmaker's uphill battle in using science to try and convince emotional jurors it hasn't lied to consumers.

A Los Angeles jury on Monday awarded $417 million to plaintiff Eva Echeverria, finding her daily application of J&J’s Johnson’s Baby Powder to her genital area for decades was the cause of her terminal ovarian cancer — a sum that far surpasses the eight- and nine-figure verdicts J&J was hit with after...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!